Q1 2025 Holdings
Filed 2025-05-15 | 69 holdings | $3.1B | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↓ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Intra-Cellular Therapies Inc(ITCIEUR) | COM | 46116X101 | $263.8M | 2,000,000 | 8.5% |
| Guardant Health Inc(GH) | COM | 40131M109 | $231.9M | 5,443,721 | 7.5% |
| Dynavax Technologies Corp(DVAX) | COM NEW | 268158201 | $230.8M | 17,791,486 | 7.5% |
| Immunovant Inc(IMVT) | COM | 45258J102 | $162.4M | 9,500,000 | 5.3% |
| Protagonist Therapeutics Inc(PTGX) | COM | 74366E102 | $145.1M | 3,000,000 | 4.7% |
| Ionis Pharmaceuticals Inc(IONS) | COM | 462222100 | $137.7M | 4,564,207 | 4.5% |
| Akero Therapeutics Inc(AKRO) | COM | 00973Y108 | $130.0M | 3,210,270 | 4.2% |
| Cytokinetics Inc(CYTK) | COM NEW | 23282W605 | $123.5M | 3,073,853 | 4.0% |
| Apellis Pharmaceuticals Inc(APLS) | COM | 03753U106 | $109.4M | 5,000,000 | 3.5% |
| Ocular Therapeutix Inc(OCUL) | COM | 67576A100 | $104.8M | 14,294,420 | 3.4% |
| Bridgebio Pharma Inc(BBIO) | COM | 10806X102 | $96.8M | 2,800,000 | 3.1% |
| Tarsus Pharmaceuticals Inc(TARS) | COM | 87650L103 | $76.2M | 1,484,266 | 2.5% |
| Viridian Therapeutics Inc(VRDN) | COM | 92790C104 | $72.5M | 5,380,449 | 2.3% |
| Structure Therapeutics Inc(GPCR) | SPONSORED ADS | 86366E106 | $71.0M | 4,100,000 | 2.3% |
| 89Bio Inc(ETNBGBP) | COM | 282559103 | $67.7M | 9,316,333 | 2.2% |
| Nurix Therapeutics Inc(NRIX) | COM | 67080M103 | $65.3M | 5,500,000 | 2.1% |
| Geron Corp(GERN) | COM | 374163103 | $60.7M | 38,176,251 | 2.0% |
| Sarepta Therapeutics Inc(SRPT) | COM | 803607100 | $57.4M | 899,731 | 1.9% |
| Ultragenyx Pharmaceutical in(RARE) | COM | 90400D108 | $48.9M | 1,350,000 | 1.6% |
| ANI Pharmaceuticals Inc(ANIP) | COM | 00182C103 | $46.9M | 700,000 | 1.5% |
| Dianthus Therapeutics Inc(DNTH) | COM | 252828108 | $42.8M | 2,357,702 | 1.4% |
| Immunocore Hldgs PLC(IMCR) | ADS | 45258D105 | $41.9M | 1,411,402 | 1.4% |
| Celldex Therapeutics Inc New(CLDX) | COM NEW | 15117B202 | $36.3M | 2,000,000 | 1.2% |
| Maze Therapeutics Inc(MAZE) | COM | 578784100 | $36.0M | 3,269,126 | 1.2% |
| Amgen Inc(AMGN) | COM | 031162100 | $35.2M | 113,035 | 1.1% |
| Xenon Pharmaceuticals Inc(XENE) | COM | 98420N105 | $33.6M | 1,000,000 | 1.1% |
| Edgewise Therapeutics Inc(EWTX) | COM | 28036F105 | $30.8M | 1,400,000 | 1.0% |
| Metsera Inc | COM | 59267L107 | $29.8M | 1,094,408 | 1.0% |
| Vaxcyte Inc(PCVX) | COM | 92243G108 | $28.3M | 750,000 | 0.9% |
| Autolus Therapeutics PLC(AUTL) | SPON ADS | 05280R100 | $27.7M | 17,849,482 | 0.9% |
| Bicara Therapeutics Inc(BCAX) | COM | 055477103 | $26.1M | 2,000,000 | 0.8% |
| Compass Pathways PLC(CMPS) | SPONSORED ADS | 20451W101 | $25.3M | 8,859,648 | 0.8% |
| Tectonic Therapeutic Inc(TECX) | COM | 878972108 | $24.8M | 1,401,938 | 0.8% |
| Abivax SA(ABVX) | SPONSORED ADS | 00370M103 | $22.4M | 3,579,209 | 0.7% |
| MBX Biosciences Inc(MBX) | COM | 55287L101 | $22.3M | 3,018,935 | 0.7% |
| GH Research PLC(GHRS) | ORDINARY SHARES | G3855L106 | $22.1M | 2,000,000 | 0.7% |
| Dyne Therapeutics Inc(DYN) | COM | 26818M108 | $20.9M | 2,000,000 | 0.7% |
| Engene Holdings Inc(ENGN) | COM | 29286M105 | $20.4M | 4,557,575 | 0.7% |
| Insmed Inc(INSM) | COM PAR $.01 | 457669307 | $19.4M | 254,751 | 0.6% |
| Galapagos NV(GLPG) | SPON ADR | 36315X101 | $18.6M | 741,068 | 0.6% |
| Sage Therapeutics Inc(SG7) | COM | 78667J108 | $16.2M | 2,038,845 | 0.5% |
| Terns Pharmaceuticals Inc(TERN) | COM | 880881107 | $15.4M | 5,576,558 | 0.5% |
| Korro BIO Inc(KRRO) | COM | 500946108 | $15.2M | 874,614 | 0.5% |
| Oruka Therapeutics Inc(ORKA) | COM | 687604108 | $14.8M | 1,444,709 | 0.5% |
| Mind Medicine Mindmed Inc(BRD1EUR) | COM NEW | 60255C885 | $14.6M | 2,500,000 | 0.5% |
| Upstream BIO Inc(UPB) | COM | 91678A107 | $14.1M | 2,299,567 | 0.5% |
| Olema Pharmaceuticals Inc(OLMA) | COM | 68062P106 | $12.9M | 3,442,833 | 0.4% |
| Septerna Inc(SEPN) | COM | 81734D104 | $11.1M | 1,912,929 | 0.4% |
| Novavax Inc(NVAX) | COM NEW | 670002401 | $9.7M | 1,518,182 | 0.3% |
| Cybin Inc(HELP) | COM NEW | 23256X407 | $9.7M | 1,529,987 | 0.3% |